January 9, 2012 -- Mindray Medical, China’s international medical device maker, said its preliminary 2011 revenues rose 25% to $878 million. The company also expects non-GAAP revenues to increase at least 10%. It predicted revenues for 2012 would climb another 18%. Investors reacted positively to the announcement, sending Mindray up more than 5%. In early going, the stock was trading at $27.90, up $1.57, on heavy volume. More details....
Stock Symbol: (NYSE: MR)
